LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/James D. Kang, M.D. Elected ABOS President
People In The News

James D. Kang, M.D. Elected ABOS President

October 31, 2023 2 min read Premium comments

Advertisement

James D. Kang, M.D. Elected ABOS President
James D. Kang, M.D. / Courtesy of Brigham and Women’s Hospital
#abos#jameskang

James D. Kang, M.D., the Thomas S. Thornhill, MD, and Karen N. Thornhill Professor of Orthopaedic Surgery at Harvard Medical School, and Chair of Orthopaedic Surgery at Brigham and Women’s Hospital, has been elected as the 2023-2024 President of the American Board of Orthopaedic Surgery (ABOS).

Scott E. Porter, M.D., M.B.A., vice chair of operations in the Department of Orthopaedic Surgery at Prisma Health-Upstate, will serve as ABOS Vice President. Kevin L. Garvin, M.D., the L. Thomas Hood, M.D. Professor and Chair, Department of Orthopaedic Surgery and Rehabilitation, University of Nebraska will serve as ABOS President-Elect.

OTW asked Dr Kang about the most vital experience he brings to this new role, he said, “I am entering my seventh year on the ABOS Board of Directors and have learned a lot through my fellow Directors as well as my time serving as Chair of the ABOS Maintenance of Certification (MOC) Committee. In addition, I have been a practicing orthopaedic spine surgeon for about 30 years and an ABOS Diplomate who is Participating in MOC, so I can see first-hand how the ABOS MOC program impacts orthopaedic surgeons.”

Wayne J. Sebastianelli, M.D., the Kalenak Professor in Orthopaedics at Penn State Health Milton S. Hershey Medical Center and Medical Director, Penn State Sports Medicine, will serve as ABOS Secretary. Kyle J. Jeray, M.D., chair of the Department of Orthopaedic Surgery at Prisma Health-Update, has been re-elected as ABOS Treasurer for a one-year term.

“This Board has elected an outstanding group of Officers,” said David F. Martin, M.D., ABOS Executive Director. “While they are all busy orthopaedic surgeons, they are all leaders in our field, serving on the boards of many organizations.”

As for how Dr. Kang will proceed in his new role, he explained to OTW, “While I am the ABOS President for the next year, it is a team effort of the 21 ABOS Directors, especially with our Vice President Dr. Scott Porter, a musculoskeletal oncologist in South Carolina. All of us want to continue making ABOS programs that are meaningful but not overly burdensome to orthopaedic surgeons while also making sure that we stay true to the ABOS’s mission of protecting the public.”

The ABOS Board of Directors consists of 12 Active Directors, six Senior Directors, two Directors-Elect, and one Public Member Director. ABOS Board Members serve one 10-year term while the Public Member Director serves a three-year renewable term. Nominations to the ABOS Board of Directors come from the American Orthopaedic Association, the American Academy of Orthopaedic Surgeons, and the American Medical Association. Officers are current Board members elected by other Board members. For a full list of ABOS Board Members, go to www.abos.org/about/board-of-directors/.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy